Literature DB >> 11899230

How does HIV cause depletion of CD4 lymphocytes? A mechanism involving virus signaling through its cellular receptors.

M W Cloyd1, J J Chen, P Adeqboyega, L Wang.   

Abstract

HIV infection causes an acquired immunodeficiency, principally because of depletion of CD4 lymphocytes. The mechanism by which the virus depletes these cells, however, is not clearly understood. Since the virus predominantly infects CD4 lymphocytes in vivo, some have assumed that HIV replication directly kills the infected cells or that the anti-HIV immune response destroys them. However, a large number of studies do not support this concept. Rather, the data strongly indicate that CD4 lymphocyte depletion is by an indirect mechanism. Several theories on various direct and indirect mechanisms are reviewed. The most plausible mechanism, which is backed by in vivo data, involves the consequences of HIV contact with resting CD4 lymphocytes, which cannot support virus replication. HIV binding to, and signaling through, CD4 and chemokine receptor molecules on resting CD4 lymphocytes and other cell types [which extensively occurs as the rare, productively infected cells (ie: infected cells producing virus) migrate among other cells through the lymphoid tissues back into the blood] induces upregulation of L-selectin and Fas. When these resting, HIV-signaled CD4 cells return to the blood, they home very rapidly back to peripheral lymph nodes and axial bone marrow, and their disappearance from the blood is likely due to their leaving the circulatory system. Approximately one-half of these cells that have been induced by HIV to home to lymph nodes are subsequently induced into apoptosis during the process of trans-endothelial migration when secondary signals are received through various homing receptors. These cells are not making HIV, which would explain the observation that CD4 cells not making HIV are the predominant cells dying in the lymph nodes of HIV+ subjects. These studies indicate that the principal mechanism of CD4 T-cell depletion by HIV is due to its use of CD4 as its primary receptor and the signaling induced through this receptor on nonpermissive (resting) T-lymphocytes. This unique mechanism of viral pathogenesis, if correct, leads to the possibility that HIV might not cause depletion of CD4 lymphocytes if it used some other receptor to infect CD4 lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11899230     DOI: 10.2174/1566524013363320

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  9 in total

1.  Human immunodeficiency virus type 1 gp120 reprogramming of CD4+ T-cell migration provides a mechanism for lymphadenopathy.

Authors:  Daniel S Green; David M Center; William W Cruikshank
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

2.  Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.

Authors:  Jason A LaBonte; Navid Madani; Joseph Sodroski
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

3.  HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression.

Authors:  Jiaxiang Ji; Miles W Cloyd
Journal:  Int Immunol       Date:  2009-02-10       Impact factor: 4.823

Review 4.  Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions.

Authors:  Julie C Gaardbo; Hans J Hartling; Jan Gerstoft; Susanne D Nielsen
Journal:  Clin Dev Immunol       Date:  2012-03-14

5.  Thirty Years with HIV Infection-Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors.

Authors:  Julie C Gaardbo; Hans J Hartling; Jan Gerstoft; Susanne D Nielsen
Journal:  AIDS Res Treat       Date:  2012-05-27

Review 6.  Pathophysiology of ocular surface squamous neoplasia.

Authors:  Stephen Gichuhi; Shin-ichi Ohnuma; Mandeep S Sagoo; Matthew J Burton
Journal:  Exp Eye Res       Date:  2014-10-18       Impact factor: 3.467

7.  Pre-test probability for SARS-Cov-2-related infection score: The PARIS score.

Authors:  Mickael Tordjman; Ahmed Mekki; Rahul D Mali; Ines Saab; Guillaume Chassagnon; Enora Guillo; Robert Burns; Deborah Eshagh; Sebastien Beaune; Guillaume Madelin; Simon Bessis; Antoine Feydy; Fadila Mihoubi; Benoit Doumenc; Luc Mouthon; Robert-Yves Carlier; Jean-Luc Drapé; Marie-Pierre Revel
Journal:  PLoS One       Date:  2020-12-17       Impact factor: 3.240

8.  Long-term clinical, immunologic and virologic impact of glucocorticoids on the chronic phase of HIV infection.

Authors:  Jean-Marie Andrieu; Wei Lu
Journal:  BMC Med       Date:  2004-05-05       Impact factor: 8.775

9.  Prevalence of HIV-related autoimmune haemolytic anaemia in Lagos, Nigeria.

Authors:  A Adediran Adewumi; A Adeyemo Titilope; V Aghayere Osamuedemen; O Osunkalu Vincent; A Akinbami Akinsegun; O Damulak Dapus; A Akanmu Sulaimon
Journal:  Niger Med J       Date:  2014-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.